Sign in

CIK 0000926617

  • Non-accelerated filer
  • Smaller reporting company

Aspira Women's Health Inc.

Sign in to watch
Ticker
AWHL
Exchange
OTC
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330595156
Phone
+1 512-519-0400
Business address
12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
Former names
VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
  1. 4 Grant or award Director acquired 3,268 shares (grant or award)
  2. 4 Grant or award CEO acquired 13,072 shares (grant or award)
  3. 4 Open-market buy 10% owner bought 28,500 shares
  4. 4 Derivatives Options or other derivatives
  5. 4 Open-market buy Chief Executive Officer bought 9,493 shares at $2.42 ($22,973)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 3 Insider Initial Statement of Ownership
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Open-market buy President & CEO bought 2,400 shares
  14. 4/A Grant or award Director acquired 13,252 shares (grant or award)
  15. 4/A Grant or award Director acquired 7,045 shares (grant or award)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market sale Secretary & General Counsel sold 980 shares at $3.37 ($3,303)
  18. 4 Open-market buy President & CEO bought 5,000 shares at $3.36 ($16,800)
  19. 4 Grant or award Chief Financial Officer acquired 30,000 shares (grant or award)
  20. 4 Grant or award Secretary & General Counsel acquired 10,000 shares (grant or award)

Page 5 of 28 · 551 filings